MPTP, selegiline, and parkinsonism.
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D006801:Humans; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000517:prevention & control*; D010627:Phenethylamines / Q000627:therapeutic use*; D011725:Pyridines / Q000037:antagonists & inhibitors*; D012642:Selegiline / Q000627:therapeutic use*
D010627:Phenethylamines; D011725:Pyridines; D012642:Selegiline; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine